Navigation Links
Isis and Collaborators Present New Research at the ATVB Annual Conference
Date:5/1/2009

the near-term to our cardiovascular pipeline, which already includes mipomersen, a CRP inhibitor and a PCSK9 inhibitor is quite exciting," said Richard Geary, Ph.D., Senior Vice President of Development at Isis Pharmaceuticals. "Inhibiting apoC-III is a promising new way to lower triglycerides to treat a potential independent risk factor for cardiovascular disease. Futhermore, the anti-atherotic effect of lowering apoC-III, which we have seen in animals, suggests that lowering apoC-III could produce reductions in atherosclerosis in man as well."

Finally, Isis and collaborators reported on the effects of antisense drugs targeting 11 beta-HSD1 and apoF. In a presentation titled "Antisense-mediated inhibition of 11 beta-HSD1 significantly decreases hepatic lipogenesis, triglyceride content and triglyceride secretion" Isis collaborator, G. Li from Columbia University, showed that antisense inhibition of 11 beta-HSD1 reduced triglycerides in both liver and blood, while also reducing body fat in animal models. 11 beta-HSD1 is an enzyme that inactivates steroids and may contribute to metabolic disease, suggesting the potential therapeutic benefit of antisense drugs inhibiting 11 beta-HSD1 to treat high triglycerides and diabetes. In a presentation titled "In vivo knock down of apolipoprotein F decreases liver triglyceride levels" S. Khetarpal from University of Pennsylvania presented research demonstrating that antisense drugs that selectively inhibit apoF reduced triglycerides in blood and liver. ApoF is another protein that carries triglycerides in blood and could offer potential therapeutic benefit in patients with diseases associated with elevated triglycerides including cardiovascular disease.

"The efficiency of our drug discovery platform offers us virtually unlimited opportunities to expand the scope of diseases we can treat with antisense drugs. We have shown that antisense inhibition of a number of ne
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
2. Rosetta Genomics and Collaborators Identify MicroRNAs That Can Accurately Discriminate Between Primary and Metastatic Tumors in the Brain
3. Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
6. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
10. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
11. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... MASON, Ohio , Dec. 23, 2014 /PRNewswire/ ... industry-leading treatment decision support to healthcare providers for ... that it has secured $30 million in equity ... Virginia C. Drosos , President and Chief ... increased clinical adoption and development of Assurex Health,s ...
(Date:12/24/2014)... Va. , Dec. 23, 2014  The ... diastolic blood pressure target for people with diabetes ... moderate or high doses of statins, in keeping ... management enacted by the American College of Cardiology ... are reflected in the most recent changes to ...
(Date:12/24/2014)... BARBARA, Calif. , Dec. 23, 2014 In ... Junior Doctors, Association of Sierra Leone , ... Sierra Leone for the treatment of local health ... While a new dedicated Ebola care center was constructed ... virus, the facility is not available for local Sierra Leonean ...
Breaking Medicine Technology:Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2
... UPPSALA, Sweden, January 13 Beactica AB, the ... research,collaboration agreement with GE Healthcare (Chalfont St. Giles, ... tools, and Uppsala,University (Sweden). The collaboration ... GE Healthcare,s Biacore(TM) technology with,enzymology expertise from ...
... Life League,s historic Personhood Conference is featuring ... cell research and regenerative medicine.(Logo: ... CEO of AVM Biotechnology and President of ... over 17 years of experience in scientific ...
Cached Medicine Technology:Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University 2Stem Cell Pioneer to Speak to A.L.L. Personhood Conference 2
(Date:12/26/2014)... December 26, 2014 DW-InductionHeating.com (DaWei Induction ... designing, researching and developing, producing and marketing of a ... the business announces their new series of induction ... of the company, induction brazing refers to ... special filler material and heat. The manager says that ...
(Date:12/25/2014)... The microscopy market is estimated to grow at ... by 2019. Optical microscopy is the largest segment ... segment is expected to show the fastest growth ... nanotechnology, technological advancements, and increasing federal support to ... Full Copy of Report @ http://www.marketsandmarkets.com/Market-Reports/world-microscopy-399.html ...
(Date:12/25/2014)... The click strand woven bamboo ... durability. Today, the business announces a click strand ... Jan. 30, 2015. , Click strand woven bamboo ... is a well-known brand in the bamboo industry. ... a reliable bamboo flooring supplier. , “We are ...
(Date:12/25/2014)... Dallas, TX (PRWEB) December 26, 2014 ... Analysis to 2023” focuses on the current treatment landscape, ... colorectal cancer market. TS-1 is an anti-cancer drug which ... administered orally and is also used for treating gastric ... gimestat and otastat potassium. The drug was first approved ...
(Date:12/25/2014)... “Every three months the trends for ... evening dress will be one of the hottest styles in ... says. Today, the company releases 26 A-line sweetheart evening dresses, ... off. , “We are trying our best to help ... latest designs. Along with affordable prices, we provide discounted delivery ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3
... Surgery International Sends First American for Prostate Cancer ... American Surgical Team to TrinidadU.S. Risk Issues First ... Fla. and DALLAS, March 11 An uninsured ... last week for prostate cancer surgery -- to ...
... Lower Cost Female Condom Increases Access to Woman-Initiated ... Health Company (NYSE Alternext: FHC) today announced approval ... for the company,s FC2 Female Condom(R) (FC2), a ... sexually transmitted infections (STIs), HIV/AIDS, and unintended pregnancy. ...
... Claims Processing and PaymentBROOMFIELD, Colo., March 11 ... LVLT ) today announced that it has ... management services company, to provide that company,s primary network ... Level 3 will deliver direct Internet access and voice ...
... Credentials in Two States to Complex RehabDAYTON, Ohio, March ... specialist with 10 years of experience, has joined ... nation,s fastest growing accredited complex rehab companies. Witten is ... Ohio, for ASM ( www.alliance-seating.com ) and provides power ...
... alliance enables the direct sales of safe, high-quality ... March 11 It,s always been easy to ... recognize the value behind reusable Therma-Kool(R) Hot & ... Cold Packs. The therapy packs provide immediate relief ...
... More Exercise and Lose Weight NAPLES, Fla., March 11 ... and wellness resource, are helping all Hoosiers begin building ... nothing. Principals Stacy Bick and Rebecca Johnson are offering all ... www.youcanmakeitfit.com for only 99 cents a month if they ...
Cached Medicine News:Health News:Modern Health Care Economics is Driving Inventiveness in Delivery of Cancer Surgery and Management of Risk 2Health News:Modern Health Care Economics is Driving Inventiveness in Delivery of Cancer Surgery and Management of Risk 3Health News:Female Health Company Receives FDA Approval for FC2 Female Condom(R) 2Health News:Female Health Company Receives FDA Approval for FC2 Female Condom(R) 3Health News:Female Health Company Receives FDA Approval for FC2 Female Condom(R) 4Health News:Female Health Company Receives FDA Approval for FC2 Female Condom(R) 5Health News:Female Health Company Receives FDA Approval for FC2 Female Condom(R) 6Health News:Level 3 Provides Primary Connectivity for MDI Holdings 2Health News:Level 3 Provides Primary Connectivity for MDI Holdings 3Health News:Nurse & Veteran Rehab Specialist, Terri Witten, Joins Fast-Growing Alliance Seating & Mobility in Ohio 2Health News:Nortech Labs, Inc. and MEDNET(TM) Make for a Notable, Natural Partnership 2Health News:Nortech Labs, Inc. and MEDNET(TM) Make for a Notable, Natural Partnership 3Health News:Make It Fit America Inc. Offers Virtually Free Fitness Service on 'Make Indiana Fit Day' 2Health News:Make It Fit America Inc. Offers Virtually Free Fitness Service on 'Make Indiana Fit Day' 3
... a scientifically advanced multinutrient that ... and full body health. It ... including a diverse array of ... lycopene and OptiBerry and important ...
... Ocuvite® Extra vitamin and mineral supplements ... original formula plus more. Ocuvite ... and higher levels of vitamins C ... also contains other antioxidants and minerals ...
HydroEye is an exclusive formulation designed to provide dry eye relief and support the body's natural tear formation. Like all ScienceBased Health formulations, it is produced in softgel form for ma...
Expert QC data management solution...
Medicine Products: